PlumX Metrics
Embed PlumX Metrics

Nasal high-flow oxygen therapy in patients with hypoxic respiratory failure: Effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation (NIV)

BMC Anesthesiology, ISSN: 1471-2253, Vol: 14, Issue: 1, Page: 66
2014
  • 125
    Citations
  • 0
    Usage
  • 234
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    125
    • Citation Indexes
      122
    • Policy Citations
      2
      • Policy Citation
        2
    • Clinical Citations
      1
      • PubMed Guidelines
        1
  • Captures
    234
  • Mentions
    2
    • News Mentions
      1
      • News
        1
    • References
      1
      • Wikipedia
        1

Most Recent News

High Flow Nasal Cannula in the Emergency Department; HFNC

STUDY INFORMATION OFFICIAL TITLE: Use of High-Flow Nasal Cannula for Acute Respiratory Failure in the Emergency Department CURRENT STATUS: Completed STUDY TYPE: Observational SPONSOR AGENCY:Hospital

Article Description

Background: Aim of the study was to compare the short-term effects of oxygen therapy via a high-flow nasal cannula (HFNC) on functional and subjective respiratory parameters in patients with acute hypoxic respiratory failure in comparison to non-invasive ventilation (NIV) and standard treatment via a Venturi mask.Methods: Fourteen patients with acute hypoxic respiratory failure were treated with HFNC (FiO 0.6, gas flow 55 l/min), NIV (FiO 0.6, PEEP 5 cm H O Hg, tidal volume 6-8 ml/kg ideal body weight,) and Venturi mask (FiO 0.6, oxygen flow 15 l/min,) in a randomized order for 30 min each. Data collection included objective respiratory and circulatory parameters as well as a subjective rating of dyspnea and discomfort by the patients on a 10-point scale. In a final interview, all three methods were comparatively evaluated by each patient using a scale from 1 (=very good) to 6 (=failed) and the patients were asked to choose one method for further treatment.Results: PaO was highest under NIV (129 ± 38 mmHg) compared to HFNC (101 ± 34 mmHg, p <0.01 vs. NIV) and VM (85 ± 21 mmHg, p <0.001 vs. NIV, p <0.01 vs. HFNC, ANOVA). All other functional parameters showed no relevant differences. In contrast, dyspnea was significantly better using a HFNC (2.9 ± 2.1, 10-point Borg scale) compared to NIV (5.0 ± 3.3, p <0.05), whereas dyspnea rating under HFNC and VM (3.3 ± 2.3) was not significantly different. A similar pattern was found when patients rated their overall discomfort on the 10 point scale: HFNC 2.7 ± 1.8, VM 3.1 ± 2.8 (ns vs. HFNC), NIV 5.4 ± 3.1 (p <0.05 vs. HFNC). In the final evaluation patients gave the best ratings to HFNC 2.3 ± 1.4, followed by VM 3.2 ± 1.7 (ns vs. HFNC) and NIV 4.5 ± 1.7 (p <0.01 vs. HFNC and p <0.05 vs. VM). For further treatment 10 patients chose HFNC, three VM and one NIV.Conclusions: In hypoxic respiratory failure HFNC offers a good balance between oxygenation and comfort compared to NIV and Venturi mask and seems to be well tolerated by patients.Trial registration: German clinical trials register: DRKS00005132.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know